AREX Capital Management’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-6,970
Closed -$377K 12
2023
Q1
$377K Sell
6,970
-4,280
-38% -$249K 0.28% 14
2022
Q4
$673K Sell
11,250
-5,000
-31% -$272K 0.4% 16
2022
Q3
$735K Sell
16,250
-4,176
-20% -$209K 0.49% 17
2022
Q2
$911K Buy
20,426
+7,542
+59% +$387K 0.56% 14
2022
Q1
$729K Sell
12,884
-134,185
-91% -$7.01M 0.42% 16
2021
Q4
$7.63M Buy
147,069
+54,051
+58% +$2.79M 3.43% 6
2021
Q3
$5.55M Buy
93,018
+20,112
+28% +$1.27M 2.59% 8
2021
Q2
$4.53M Buy
+72,906
New +$4.86M 2.15% 9

Other funds holding EHC

AREX Capital Management's EHC Position: Q2 2023 in Review

AREX Capital Management sold out of Encompass Health (EHC) in Q2 2023, closing a stake of 6,970 shares — an estimated $377K sold.

AREX Capital Management first reported a position in EHC in Q2 2021 and held it in 8 quarters. The position peaked at $7.63M in Q4 2021. 385 funds tracked by Wall St. Rank hold EHC as of Q2 2023.

  • AREX Capital Management reported no remaining Encompass Health position as of Q2 2023 after selling out during the quarter.
  • AREX Capital Management sold 6,970 Encompass Health shares in Q2 2023, an estimated $377K.
  • AREX Capital Management first reported a position in Encompass Health in Q2 2021 and held it in 8 quarters.
  • AREX Capital Management's Encompass Health position peaked at $7.63M in Q4 2021.
  • 385 funds tracked by Wall St. Rank held Encompass Health as of Q2 2023.

Based on AREX Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.